Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study.
Giovanni FucàAlessandra RaimondiMichele PrisciandaroSara LonardiChiara CremoliniMargherita RattiMatteo ClavarezzaRoberto MurialdoAndrea Sartore-BianchiValeria SmiroldoRosa BerenatoPatrizia RaccaFrancesca BergamoSalvatore CoralloMaria Di BartolomeoFilippo G De BraudFederica MoranoFilippo PietrantonioPublished in: The oncologist (2022)
Reinduction strategies with anti-EGFR-based regimens are commonly used in clinical practice. Our data highlight the importance of clinical-molecular selection for re-treatments and the need for prospective strategy trials in selected populations.